Parallel 1b: AAV as a gene therapy tool from virus to vector

Thursday 17 March

16h55 - 19h00

Chair:

Guangping Gao, University of Massachusetts

17h00

INV018

Dirk Grimm

Heidelberg University

Faster, higher, stronger - a short history of record-breaking AAV vector technologies

17h30

Hildegard Büning

Hannover Medical School

Filling the pipeline - the next generation of AAV vectors for gene therapy

18h00

Guangping Gao

University of Massachusetts

Potential roadblocks to clinical translation and commercialization of AAV gene Tx: Assessment and mitigation strategies